Systematic development of optimized SNEDDS of artemether with improved biopharmaceutical and antimalarial potential

References

• Abosi AO, Raseroka BH. (2003). In vivo antimalarial activity of Vernonia amygdalina. Br J Biomed Sci 60:89–91
   PubMed Web of Science ®Google Scholar
• Aditya NP, Chimote G, Gunalan K, et al. (2012). Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice. Exp Parasitol 131:292–9
   PubMed Web of Science ®Google Scholar
• Ahsan T, Ali H, Bkaht SF, et al. (2008). Jaundice in falciparum malaria; changing trends in clinical presentation-a need for awareness. J Pak Med Assoc 58:616–21
   PubMedGoogle Scholar
• Bali V, Ali M, Ali J. (2010). Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces 76:410–20
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Beg S, Katare OP, et al. (2014). QbD-oriented development of self-nanoemulsifying drug delivery systems (SNEDDS) of valsartan with improved biopharmaceutical performance. Curr Drug Deliv 12:544–63
   Web of Science ®Google Scholar
• Bandyopadhyay S, Katare OP, Singh B. (2012). Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 100:50–61
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Katare OP, Singh B. (2014). Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv 11:479–92
   PubMed Web of Science ®Google Scholar
• Beg S, Jena SS, Patra Ch N, et al. (2013). Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential. Colloids Surf B Biointerfaces 101:414–23
   PubMed Web of Science ®Google Scholar
• Beg S, Sandhu PS, Batra RS, et al. (2015a). QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv 22:765–84
   PubMed Web of Science ®Google Scholar
• Beg S, Sharma G, Thanki K, et al. (2015b). Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: systematic development, in vitro, ex vivo and in vivo evaluation. Int J Pharm 493:466–82
   PubMed Web of Science ®Google Scholar
• Beg S, Swain S, Singh HP, et al. (2012). Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech 13:1416–27
   PubMed Web of Science ®Google Scholar
• Cachet N, Hoakwie F, Bertani S, et al. (2009). Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae). Antimicrob Agents Chemother 53:4393–8
   PubMed Web of Science ®Google Scholar
• Elgart A, Cherniakov I, Aldouby Y, et al. (2013). Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol. Pharm Res 30:3029–44
   PubMed Web of Science ®Google Scholar
• Gershkovich P, Hoffman A. (2007). Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins. Eur J Pharm Sci 32:24–32
   PubMed Web of Science ®Google Scholar
• Grace JM, Skanchy DJ, Aguilar AJ. (1999). Metabolism of artelinic acid to dihydroqinqhaosu by human liver cytochrome P4503A. Xenobiotica 29:703–17
   PubMed Web of Science ®Google Scholar
• Haque A, Best SE, Amante FH, et al. (2011). High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology. Infect Immun 79:1882–8
   PubMed Web of Science ®Google Scholar
• Jain NK, Gupta U. (2008). Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability. Expert Opin Drug Metab Toxicol 4:1035–52
   PubMed Web of Science ®Google Scholar
• Keohane K, Rosa M, Coulter IS, Griffin BT. (2015). Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres. Drug Dev Ind Pharm 42:245–53
   PubMed Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, et al. (2015). Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv 22:552–61
   PubMed Web of Science ®Google Scholar
• Kochar DK, Singh P, Agarwal P, et al. (2003). Malarial hepatitis. J Assoc Physicians India 51:1069–72
   PubMedGoogle Scholar
• Lin AJ, Zikry AB, Kyle DE. (1997). Antimalarial activity of new dihydroartemisinin derivatives: 7,4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids. J Med Chem 40:1396–400
   PubMed Web of Science ®Google Scholar
• Makanga M. (2014). A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar J 13:291–306
   PubMed Web of Science ®Google Scholar
• Makanga M, Bassat Q, Falade CO, et al. (2011). Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis. Am J Trop Med Hyg 85:793–804
   PubMed Web of Science ®Google Scholar
• Mandawgade SD, Sharma S, Pathak S, Patravale VB. (2008). Development of SMEDDS using natural lipophile: application to beta-Artemether delivery. Int J Pharm 362:179–83
   PubMed Web of Science ®Google Scholar
• McGready R, Tan SO, Ashley EA, et al. (2008). A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. PLoS Med 5:e253
   PubMed Web of Science ®Google Scholar
• Mohd Ridzuan MA, Ruenruetai U, Noor Rain A, et al. (2006). Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice. Trop Biomed 23:140–6
   PubMed Web of Science ®Google Scholar
• Mullertz A, Ogbonna A, Ren S, Rades T. (2010). New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol 62:1622–36
   PubMed Web of Science ®Google Scholar
• Murota K, Cermak R, Terao J, Wolffram S. (2013). Influence of fatty acid patterns on the intestinal absorption pathway of quercetin in thoracic lymph duct-cannulated rats. Br J Nutr 109:2147–53
   PubMed Web of Science ®Google Scholar
• Na Bangchang K, Karbwang J, Thomas CG, et al. (1994). Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria. Br J Clin Pharmacol 37:249–53
   PubMed Web of Science ®Google Scholar
• Narang AS, Delmarre D, Gao D. (2007). Stable drug encapsulation in micelles and microemulsions. Int J Pharm 345:9–25
   PubMed Web of Science ®Google Scholar
• Negi P, Singh B, Sharma G, et al. (2015). Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Deliv 23:951–67
   Web of Science ®Google Scholar
• Peters W. (1975). The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol 69:155–71
   PubMed Web of Science ®Google Scholar
• Pinmai K, Hiriote W, Soonthornchareonnon N, et al. (2010). In vitro and in vivo antiplasmodial activity and cytotoxicity of water extracts of Phyllanthus emblica, Terminalia chebula, and Terminalia bellerica. J Med Assoc Thai 93:S120–6
   Google Scholar
• Porter CJ, Charman WN. (2001a). Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 50:61–80
   PubMed Web of Science ®Google Scholar
• Porter CJ, Charman WN. (2001b). Transport and absorption of drugs via the lymphatic system. Adv Drug Deliv Rev 50:1–2
   PubMed Web of Science ®Google Scholar
• Porter CJ, Pouton CW, Cuine JF, Charman WN. (2008). Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev 60:673–91
   PubMed Web of Science ®Google Scholar
• Sandhu PS, Beg S, Mehta F, et al. (2015). Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. Expert Opin Drug Deliv 12:1809–22
   PubMed Web of Science ®Google Scholar
• Shah NH, Carvajal MT, Patel CI, et al. (1994). Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 106:15–23
   Web of Science ®Google Scholar
• Shah P, Mashru R. (2008). Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique. AAPS PharmSciTech 9:494–500
   PubMed Web of Science ®Google Scholar
• Sharma G, Beg S, Thanki K, et al. (2015). Systematic development of novel cationic self-nanoemulsifying drug delivery systems of candesartan cilexetil with enhanced biopharmaceutical performance. RSC Adv 5:71500–13
   Web of Science ®Google Scholar
• Sheiban AK. (1999). Prognosis of malaria associated severe acute renal failure in children. Ren Fail 21:63–6
   PubMed Web of Science ®Google Scholar
• Singh B, Bandopadhyay S, Kapil R, et al. (2009). Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst 26:427–521
   PubMed Web of Science ®Google Scholar
• Singh B, Beg S, Khurana RK, et al. (2014). Recent advances in self-emulsifying drug delivery systems (SEDDS). Crit Rev Ther Drug Carrier Syst 31:121–85
   PubMed Web of Science ®Google Scholar
• Singh B, Dahiya M, Saharan V, Ahuja N. (2005a). Optimizing drug delivery systems using systematic “design of experiments” Part II: retrospect and prospects. Crit Rev Ther Drug Carrier Syst 22:215–94
   PubMed Web of Science ®Google Scholar
• Singh B, Kapil R, Nandi M, Ahuja N. (2011a). Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv 8:1341–60
   PubMed Web of Science ®Google Scholar
• Singh B, Kaur T, Singh S. (1997). Correction of raw dissolution data for loss of drug during sampling. Indian J Pharm Sci 59:196–9
   Google Scholar
• Singh B, Khurana L, Bandyopadhyay S, et al. (2011b). Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv 18:599–612
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. (2005b). Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 22:27–105
   PubMed Web of Science ®Google Scholar
• Singh B, Singh R, Bandyopadhyay S, et al. (2013). Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids Surf B Biointerfaces 101:465–74
   PubMed Web of Science ®Google Scholar
• Singh B, Singh S. (1998). A Comprehensive computer program for study of drug release kinetics from compressed matrices. Indian J Pharm Sci 60:313–16
   Google Scholar
• Singh RP, Kashiwamura S, Rao P, et al. (2002). The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. J Immunol 168:4674–81
   PubMed Web of Science ®Google Scholar
• Sullivan AD, Ittarat I, Meshnick SR. (1996). Patterns of haemozoin accumulation in tissue. Parasitology 112:285–94
   PubMed Web of Science ®Google Scholar
• Suputtamongkol Y, Newton PN, Angus B, et al. (2001). A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria. Br J Clin Pharmacol 52:655–61
   PubMed Web of Science ®Google Scholar
• Tran TH, Day NP, Nguyen HP, et al. (1996). A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 335:76–83
   PubMed Web of Science ®Google Scholar
• Truong DH, Tran TH, Ramasamy T, et al. (2015). Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib. AAPS PharmSciTech. [Epub ahead of print]. DOI: 10.1208/s12249-015-0370-5
   PubMed Web of Science ®Google Scholar
• Van Hensbroek MB, Onyiorah E, Jaffar S, et al. (1996). A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 335:69–75
   PubMed Web of Science ®Google Scholar
• Wei L, Sun P, Nie S, Pan W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm 31:785–94
   PubMed Web of Science ®Google Scholar
• Wilairatana P, Looareesuwan S, Charoenlarp P. (1994). Liver profile changes and complications in jaundiced patients with falciparum malaria. Trop Med Parasitol 45:298–302
   PubMedGoogle Scholar
• Yang B, Lin J, Chen Y, Liu Y. (2009). Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode. Bioorg Med Chem 17:6311–17
   PubMed Web of Science ®Google Scholar
• Yu L. (2008). Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 25:781–91
   PubMed Web of Science ®Google Scholar